We report the case of a patient with tardive dystonia and a history of psychiatric illness who showed signs of neuroleptic malignant syndrome (NMS) after chronic treatment with tetrabenazine. The first symptom was a mental status change 'consisting of confusion, disorganized thinking, paranoid delus
Normal neuropathological findings after neuroleptic malignant syndrome
✍ Scribed by Hannu J. Koponen; Ulla Lepola; Esa Leinonen; Leo Paljärvi
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 235 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0885-6222
No coin nor oath required. For personal study only.
✦ Synopsis
Neuroleptic malignant syndrome (NMS) is a rare, life-threatening complication of antipsychotic drug treatment. Its pathophysiology is controversial, and the same is true for the findings in post-mortem studies on central nervous system pathology. In this report we present a patient who died two and a half months after suffering NMS. The findings in a thorough neuropathological examination were normal suggesting that the postulated dopamine receptor blockade in NMS is not associated with a structural central nervous system damage.
KEY worms-Adverse drug reaction, antipsychotic drugs, neuroleptic malignant syndrome, neuropathology.
📜 SIMILAR VOLUMES
Successful use of risperidone after neuroleptic malignant syndrome (NMS): a 1-year follow-up Neuroleptic malignant syndrome (NMS) is a rare and an acute life-threatening reaction that can occur in patients on neuroleptic medication. Few authors have addressed the issue of re-challenge in previous NM